This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Smithkline Beecham Corporation. Active years: 2006-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2007
Title: Ronda Davis: Innovator in Angiogenesis Modulation
Introduction
Ronda Davis is a notable inventor based in Durham, NC (US). She has made significant contributions to the field of medical research, particularly in the development of compounds that modulate angiogenesis. With a total of two patents to her name, her work is paving the way for advancements in the treatment of hyperproliferative diseases.
Latest Patents
Ronda Davis's latest patents include innovative pyrimidine derivatives that serve as VEGFR2 inhibitors. These compounds are described as pyrimidineamines that function as angiogenesis modulators. The patents detail methods for synthesizing these pyrimidine derivatives and outline their applications in treating hyperproliferative diseases.
Career Highlights
Ronda Davis is currently associated with Smithkline Beecham Corporation, where she continues to push the boundaries of medical research. Her work has garnered attention for its potential impact on therapeutic strategies for various diseases.
Collaborations
Ronda collaborates with talented individuals such as Amogh Boloor and Mui Cheung, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Ronda Davis stands out as an influential inventor in the field of angiogenesis modulation. Her patents and ongoing research efforts are crucial in the fight against hyperproliferative diseases, showcasing her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile